Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Viveve Medical Inc    VIVE

VIVEVE MEDICAL INC

(VIVE)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/17/2019 05/20/2019 05/21/2019 05/22/2019 05/23/2019 Date
0.59786(c) 0.6024(c) 0.61(c) 0.61(c) 0.605(c) Last
2 661 762 541 451 1 259 140 600 902 991 161 Volume
+4.91% +0.76% +1.26% 0.00% -0.82% Change
More quotes
Financials (USD)
Sales 2019 19,1 M
EBIT 2019 -28,2 M
Net income 2019 -33,2 M
Debt 2019 -
Yield 2019 -
Sales 2020 27,7 M
EBIT 2020 -25,5 M
Net income 2020 -29,0 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020
Capi. / Sales2019 1,47x
Capi. / Sales2020 1,02x
Capitalization 28,1 M
More Financials
Company
Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three... 
More about the company
Surperformance© ratings of Viveve Medical Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VIVEVE MEDICAL INC
05/23VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Lis..
AQ
05/16VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Lis..
AQ
05/09VIVEVE MEDICAL : Management's Discussion and Analysis of Financial Condition and..
AQ
05/09VIVEVE MEDICAL, INC. : Results of Operations and Financial Condition, Financial ..
AQ
03/16VIVEVE MEDICAL : Health Tech Firm Completes Enrollment for Female Sexual Functio..
AQ
03/15VIVEVE MEDICAL : Management's Discussion and Analysis of Financial Condition and..
AQ
03/14VIVEVE MEDICAL, INC. : Results of Operations and Financial Condition, Financial ..
AQ
01/30VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Lis..
AQ
01/16VIVEVE MEDICAL, INC. : Results of Operations and Financial Condition, Costs Asso..
AQ
01/16Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 R..
GL
More news
Analyst Recommendations on VIVEVE MEDICAL INC
More recommendations
Sector news : Advanced Medical Equipment & Technology - NEC
05/23DANAHER : FDA Alerts Hospitals, Labs, Others About Recall of Beckman Coulter Blo..
DJ
05/17EXCLUSIVE : FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft ..
RE
05/16Thermo Fisher to Buy Ireland API Plant From GlaxoSmithKline
DJ
05/16Philips's Netherlands Operations Now Use Only Green Energy
DJ
05/15PATRICK THOMAS : Agilent Technologies Shares Fall After Slower Sales From China
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Chart VIVEVE MEDICAL INC
Duration : Period :
Viveve Medical Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VIVEVE MEDICAL INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 3,14 $
Spread / Average Target 419%
EPS Revisions
Managers
NameTitle
Scott C. Durbin Chief Executive Officer & Director
James G. Atkinson President & Chief Business Officer
Steven L. Basta Chairman
Marty Kerber Vice President-Operations
Jim B. Robbins Chief Financial & Accounting Officer
Sector and Competitors
1st jan.Capitalization (M$)
VIVEVE MEDICAL INC-42.38%28
THERMO FISHER SCIENTIFIC21.39%108 659
DANAHER CORPORATION27.75%94 317
INTUITIVE SURGICAL-1.07%56 035
BOSTON SCIENTIFIC CORPORATION6.76%52 469
ILLUMINA3.01%45 986